NEW DELHI: All India Institute Of Medical Sciences (AIIMS) Delhi will start screening children for the indigenous Covaxin trials from Monday, news agency ANI reported quoting sources.
Last week, AIIMS in Patna began clinical trials of Covaxin for children in the age group of 2 to 18 years.
The move came after the Drugs Controller General of India (DGCI) granted permission for the phase 2-3 clinical trial of Covaxin on children.
AIIMS-Delhi has been selected as one of the sites for the trial along with other institutes such as AIIMS-Patna and Meditrina Institute of Medical Sciences, Nagpur.
“Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years,” the government had earlier said.
AIIMS Delhi to screen children for Covaxin trials from Monday
